文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

欧洲和北美脓毒性休克的频率与死亡率:系统评价与荟萃分析

Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis.
PubMed 文献 · Crit Care · 2019-05-31
一句话结论欧洲和北美ICU中脓毒性休克频率约8.3%–10.4%,ICU死亡率37.3%、住院死亡率39.0%、28/30天死亡率36.7%。

该研究系统检索2005年1月1日至2018年2月20日MEDLINE、Embase和Cochrane Library,纳入71篇观察性研究,采用随机效应模型荟萃分析。ICU入院时诊断的脓毒性休克频率为10.4%(95%CI 5.9–16.1%),ICU期间任意时间诊断为8.3%(95%CI 6.1–10.7%)。ICU死亡率37.3%(95%CI 31.5–43.5%),住院死亡率39.0%(95%CI 34.4–43.9%),28/30天死亡率36.7%(95%CI 32.8–40.8%)。研究间存在显著异质性,可能源于诊断标准定义与应用差异以及不同地区和国家的治疗护理差异。

要点

  • 欧洲和北美ICU中,入院时诊断的脓毒性休克频率为10.4%(95%CI 5.9–16.1%)。
  • ICU期间任意时间诊断的脓毒性休克频率为8.3%(95%CI 6.1–10.7%)。
  • 脓毒性休克ICU死亡率为37.3%(95%CI 31.5–43.5%)。
  • 脓毒性休克住院死亡率为39.0%(95%CI 34.4–43.9%),28/30天死亡率为36.7%(95%CI 32.8–40.8%)。

适用人群与场景

  • 欧洲和北美ICU中诊断为脓毒性休克的成人患者(基于纳入的观察性研究)。

研究设计与关键结果

  • 研究类型:系统评价与荟萃分析,纳入71篇观察性研究,检索MEDLINE、Embase和Cochrane Library(2005年1月1日至2018年2月20日)。
  • ICU入院时诊断的脓毒性休克频率为10.4%(95%CI 5.9–16.1%)。
  • ICU期间任意时间诊断的脓毒性休克频率为8.3%(95%CI 6.1–10.7%)。
  • ICU死亡率为37.3%(95%CI 31.5–43.5%),住院死亡率为39.0%(95%CI 34.4–43.9%),28/30天死亡率为36.7%(95%CI 32.8–40.8%)。
  • 观察到显著的研间异质性。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析(观察性研究)。
  • 局限:观察到显著的研间异质性,可能源于诊断标准定义与应用差异以及不同地区和国家的治疗护理差异。

对床旁实践的改变

  • 该研究提示欧洲和北美ICU中脓毒性休克仍常见,死亡率约38%,可能有助于指导资源分配。
  • 作者认为观察到的异质性可能源于诊断标准定义与应用差异以及不同地区和国家的治疗护理差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Septic shock is the most severe form of sepsis, in which profound underlying abnormalities in circulatory and cellular/metabolic parameters lead to substantially increased mortality. A clear understanding and up-to-date assessment of the burden and epidemiology of septic shock are needed to help guide resource allocation and thus ultimately improve patient care. The aim of this systematic review and meta-analysis was therefore to provide a recent evaluation of the frequency of septic shock in intensive care units (ICUs) and associated ICU and hospital mortality.

METHODS: We searched MEDLINE, Embase, and the Cochrane Library from 1 January 2005 to 20 February 2018 for observational studies that reported on the frequency and mortality of septic shock. Four reviewers independently selected studies and extracted data. Disagreements were resolved via consensus. Random effects meta-analyses were performed to estimate pooled frequency of septic shock diagnosed at admission and during the ICU stay and to estimate septic shock mortality in the ICU, hospital, and at 28 or 30 days.

RESULTS: The literature search identified 6291 records of which 71 articles met the inclusion criteria. The frequency of septic shock was estimated at 10.4% (95% CI 5.9 to 16.1%) in studies reporting values for patients diagnosed at ICU admission and at 8.3% (95% CI 6.1 to 10.7%) in studies reporting values for patients diagnosed at any time during the ICU stay. ICU mortality was 37.3% (95% CI 31.5 to 43.5%), hospital mortality 39.0% (95% CI 34.4 to 43.9%), and 28-/30-day mortality 36.7% (95% CI 32.8 to 40.8%). Significant between-study heterogeneity was observed.

CONCLUSIONS: Our literature review reaffirms the continued common occurrence of septic shock and estimates a high mortality of around 38%. The high level of heterogeneity observed in this review may be driven by variability in defining and applying the diagnostic criteria, as well as differences in treatment and care across settings and countries.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Vincent JL, Jones G, David S, et al. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care. 2019. PMID: 31151462. doi:10.1186/s13054-019-2478-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。